Status:
RECRUITING
Feasibility Trial of ScarWork for Post-breast Surgery Pain Syndrome.
Lead Sponsor:
University College London Hospitals
Collaborating Sponsors:
University of West London
Conditions:
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Breast cancer is the most common cancer in women in the United Kingdom (UK). Most women are treated with a combination of surgery and radiotherapy. While these treatments are effective, they can cause...
Detailed Description
Background Breast cancer is the most common cancer among women in the United Kingdom (UK). Each year, around 57,000 women are diagnosed. Many are treated with a combination of breast-conserving surger...
Eligibility Criteria
Inclusion
- Over the age of 18
- Early breast cancer patients who have had breast surgery with curative intent
- Radiotherapy completed ≥ 6 months previously
- In remission with no sign of active local disease
- Registering a score of ≥3 on perceived pain intensity or pain burden on a 10-point numerical rating scale (NRS)
- English speaking and able to communicate reasonably well
- Able to give informed consent
- Willing to attend for regular treatment at RLHIM
Exclusion
- History of post-breast surgery wound complications
- History of breast surgery unrelated to breast cancer treatment
- History of previous ScarWork therapy
- Diagnosis of lymphoedema
- Severe co-morbidities or cognitive disability
- Receiving physiotherapy for post-breast surgery pain syndrome at the time of trial
Key Trial Info
Start Date :
June 20 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07206394
Start Date
June 20 2025
End Date
June 30 2026
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal London Hospital for Integrated Medicine
London, United Kingdom